Alterations in peripheral T‐cell and B‐cell subsets in the ankylosing spondylitis patients with gut inflammation
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15324 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Xiqing Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, B-Lymphocyte Subsets, Colitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Key-Area Research and Development Program of Guangdong Province, Guangdong Clinical Research Center of Immune disease.
Abstract (Originalsprache)
Aim
This study investigates changes in immune cell subsets in peripheral blood of ankylosing spondylitis (AS) patients with colitis or terminal ileitis. It aims to explore the connection between changes in lymphocyte subsets and gut inflammation, providing insights for early detection.
Methods
Overall, 50 AS patients undergoing colonoscopy were enrolled. Flow cytometry was employed to analyze lymphocyte subsets, including T and B cells, in peripheral blood. Disease activity was assessed using CRP, ESR, BASDAI, ASDAS‐CRP, and ASDAS‐ESR.
Results
Compared to AS patients without gut inflammation, those with colorectal inflammation showed a significant increase in total T cells ( p < .05), an increase in exhausted CD4 + T cells ( p < .05), and a decrease in Th2 cells and total Tc cells ( p < .05). Notably, in AS patients with terminal ileitis, there was an increase in total B cells and classic switched B cells ( p < .05), with a decrease in double‐positive T cells ( p < .05). However, no significant differences were observed in the distribution of Tfh‐cell subpopulations (Tfh1, Tfh2, Tfh17) and Tc‐cell subpopulations (Tc1, Tc2, Tc17) between AS patients with either colorectal inflammation or terminal ileitis ( p > .05). We explored the relationship between disease activity scores, ESR, CRP, and lymphocyte subsets, but found no statistically significant correlation between them.
Conclusion
Distinct immune patterns may exist in AS with different types of intestinal inflammation. Colitis in AS is primarily characterized by a significant increase in exhausted CD4 + T cells, along with a decrease in Th2 cells. In contrast, terminal ileum inflammation in AS is marked by an increase in total B cells and classic switched B cells. These findings offer new insights for early detection and therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Department of Rheumatology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
- Shenzhen Institute of Immunomedicine Transformation (Longhua), Shenzhen, China.
ORCID-Profile: Ya Xie, Shenghui Wen
Förderung
- Key-Area Research and Development Program of Guangdong Province
- Guangdong Clinical Research Center of Immune disease
Zitieren
APA
Luo, X., Li, J., Yang, M., Tu, L., Xie, Y., Lv, Q., Wen, S., Wen, X., Zhou, L., & Gu, J. (2024). Alterations in peripheral T‐cell and B‐cell subsets in the ankylosing spondylitis patients with gut inflammation. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15324
Vancouver
Luo X, Li J, Yang M, Tu L, Xie Y, Lv Q, et al. Alterations in peripheral T‐cell and B‐cell subsets in the ankylosing spondylitis patients with gut inflammation. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15324
BibTeX
@article{Luo2024,
author = {Luo, Xiqing and Li, Jinwei and Yang, Mingcan and Tu, Liudan and Xie, Ya and Lv, Qing and Wen, Shenghui and Wen, Xianghui and Zhou, Liuzhong and Gu, Jieruo},
title = {Alterations in peripheral T‐cell and B‐cell subsets in the ankylosing spondylitis patients with gut inflammation},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15324}
}
EUVIMED